JB Capital’s Medifast MED Stock Holding History

JB Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,963	Closed	-$1.08M	–	204
2022 Q2	$1.08M	Buy	5,963 +555	+10%	+$99.3K	0.12%	92
2022 Q1	$924K	Buy	5,408 +2,843	+111%	+$536K	0.09%	113
2021 Q4	$537K	Buy	2,565 +210	+9%	+$43.4K	0.05%	160
2021 Q3	$454K	Buy	+2,355	New	+$579K	0.06%	179

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JB Capital's MED Position: Q3 2022 in Review

JB Capital sold out of Medifast (MED) in Q3 2022, closing a stake of 5,963 shares — an estimated $1.08M sold.

JB Capital first reported a position in MED in Q3 2021 and held it in 4 quarters. The position peaked at $1.08M in Q2 2022. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

JB Capital reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
JB Capital sold 5,963 Medifast shares in Q3 2022, an estimated $1.08M.
JB Capital first reported a position in Medifast in Q3 2021 and held it in 4 quarters.
JB Capital's Medifast position peaked at $1.08M in Q2 2022.
263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on JB Capital's 13F filing for Q3 2022, filed 14 Oct 2022.